Singapore, July 7 -- South Korea-based Neurophet, an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, has signed a supply agreement with Raffles Medical for its neurodegenerative brain imaging analysis software, Neurophet AQUA.

Neurophet AQUA is a neurodegenerative brain imaging analysis software that performs ultra-fast quantitative analysis of patients' brain MRI scans, enabling the assessment of brain atrophy and white matter degeneration. It quantifies structural changes in the brain-such as atrophy and white matter alterations-observed in neurodegenerative diseases including Alzheimer's disease and vascular dementia, and delivers customized analysis reports tailored to individual patients. ...